A number of factors decided where to publish the research, such as journal reputation, readership and community, speed of publication, and citations for articulating high-quality, comprehensive, original research. Quality research and its access to the world is an important aspect of scientific community. A scientometric impact factor is frequently used for the relative importance of a journal within its field. The JGDT Editor James Smith found the article in Cancer Letters, 2022 Impact Factor: 9.756 - Subject: Oncology, as a PIONEERING publication (Journal of Genetic Disorders and Therapy, invitation for original articles, email message from editor@resmotion.biz to jjspychala@wp.pl, 1:55 pm on 26 September 2022). Bioorganic Chemistry (2022 Impact Factor: 5.307, Subject: Organic Chemistry) is dedicated to publishing and disseminating the most exceptionally significant, breakthrough research on chemical biology. Dr. J.J. Spychala really did pioneering work in anticancer research and bioorganic chemistry. He is listed in the highly-respected official reference book: Dictionary of International Biography - 39th Edition edited by Sara Rains, the IBC Person (International Biographical Centre, Cambridge, England) and it will be maintained forever. 1. Jaroslaw Spychala, Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023. Editor-in-chief Klaus Höffken, Prof. Dr. med.: Hämatologe und Onkologe, ehem. Ärztlicher Direktor Universitätsklinikum Düsseldorf, Welserstrasse 21, Metropolregion Berlin/Brandenburg, Berlin, Germany. https://doi.org/10.1007/s00432-023-04604-6 2. Jaroslaw Spychala, Selective Cytostatic and Cytotoxic Anticancer Effects of Bisfunctional Agents: A Strategy for the Design of DNA Binding Agents, CANCER LETTERS, vol. 281(2), pages 203-212, 2009. Editor-in-chief Manfred Schwab, University Professor of Genetics, Tumor Genetics Division, German Cancer Research Center, Heidelberg, Germany. PMID: 19303699. https://doi.org/10.1016/j.canlet.2009.02.026 3. Jaroslaw Spychala, The Usefulness of Cyclic Diamidines with Different Core-substituents as Antitumor Agents, BIOORGANIC CHEMISTRY, vol. 36(4), pages 183-189, 2008. Editor Christian P. Whitman, Professor of Chemical Biology & Medicinal Chemistry, San Diego, California, USA. PMID: 18571215. https://doi.org/10.1016/j.bioorg.2008.05.002 4. Jaroslaw Spychala, A Convenient Way to Methylated 2-Imidazolines. Syntheses of Fluorene and Triazine Cyclic Diamidines, MONATSHEFTE FUER CHEMIE, vol. 137(9), pages 1203-1210, 2006. Editor Prof. Dr. Fritz Pittner (Editorial Board), Max F. Perutz Labolatories, Vienna BioCenter, University of Vienna, Vienna, Austria. https://doi.org/10.1007/s00706-006-0516-y